The N°1, healthy, rich in learning webinar about claims

The N°1, healthy, rich in learning webinar about claims
February 28, 2023

Is your product a No. 1 seller? Good for your health or rich in fiber? Does it contain no parabens? Do you want to shout it loudly from the rooftops or at least on your packaging?

During this webinar, you will get an overview of the principles that need to be respected in order to claim your products legally. Our experts will discuss the rules for No. 1 claims, cosmetic claims and health and nutrition claims, and will give you an overview of the most important issues as well as practical guidelines.

This webinar has been awarded one point of continuous education by the Institut des Juristes d’Entreprise / Instituut voor Bedrijfsjuristen.

We hope to see you online on 14 March, from 13:30 to 14:30!

Your hosts

  • Mathieu Maniet

    Managing Associate

  • François Lambert

    Associate

  • Karel Martens

    Associate

Recommended articles

February 12, 2025

New year, new policy: CPVO updates its public access to documents policy

The Community Plant Variety Office (CPVO) recently revised its public access to documents policy to align with the European Union (EU)’s evolving transparency standards. Effective since 15 January 2025, the new policy seeks to ensure broad access to all documents that the CPVO holds, while protecting private parties’ commercial interests. In particular, a system of prior confidentiality requests has been put in place for applicants of Community plant variety rights (CPVR).

Read on
February 05, 2025

European Commission proposes new PPP labelling requirements

On 6 January 2025, the European Commission published a draft proposal aimed at further harmonising labelling requirements for plant protection products (PPPs) in the European Union (EU). The proposal intends to repeal the existing labelling rules and introduce certain new requirements, including mandatory digital labelling. Since the draft proposal has not yet been formally adopted, some changes to the final version remain possible.

Read on
December 09, 2024

CJEU C-793/22 Biohemp – Indoor Cannabis Cultivation: The CJEU Weighs in

The Cannabis sativa L. plant serves a wide range of purposes, many of which are uncontroversial. It can be grown in the EU, in which context it is commonly called ‘hemp’. The plant notably produces cannabidiol (CBD), which the Court of Justice of the European Union has unequivocally ruled is not a narcotic drug. Nonetheless, some EU Member States remain reluctant to accept hemp cultivation.

Read on